Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma
European Journal of Ophthalmology, 06/18/09
Hasanreisoglu M et al. - Intravitreal bevacizumab is beneficial for the treatment of anterior segment neovascularization and NVG when used as an adjunct, making the administration of additional treatment for the underlying cause possible. Bevacizumab should be instituted promptly after diagnosis, before irreversible anatomic and functional damage occurs.
Related Articles
Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09
Relevance Score: 93%
Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09
Relevance Score: 92%
Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09
Relevance Score: 91%
Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09
Relevance Score: 91%
Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09
Relevance Score: 91%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration
Journal of Clinical Ultrasound, 12/03/09
N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients
American Journal of Therapeutics, 12/02/09
Photodynamic Therapy With and Without Adjunctive Intravitreal Triamcinolone Acetonide
Ophthalmic Surgery, Lasers and Imaging, 12/01/09
Today in Glaucoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Downregulation of Serum IGF-1 for Treatment of Early Worsening of Diabetic Retinopathy: A Long-Term Follow-Up of Two Cases
Ophthalmologica, 12/04/09
Surgical revision of dysfunctional filtration blebs with bleb preservation, sliding conjunctival flap and fibrin glue
Eye, 12/03/09
Bleb Needling in Encapsulated Filtering Blebs: Evaluation by Optical Coherence Tomography
Ophthalmologica, 12/03/09
Article Search
Sponsor


See Latest Articles


